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Abstract: Purpose
Restoration of sinus rhythm may result in an improvement of left heart function in
patients with atrial fibrillation (AF). Cardiovascular magnetic resonance (CMR) feature
tracking (FT) technique may help detect subtle wall-motion abnormalities.
Consequently this study aimed to analyse existence and reversibility of subclinical
cardiac dysfunction following atrial fibrillation ablation.
Methods
28 consecutive patients (mean age: 61 years) with paroxysmal AF underwent
pulmonary vein isolation (PVI). CMR imaging was done 3 (±3) days before and 3.4
(±1.1) months after ablation. Left heart function was determined by performing FT
analysis. Statistical analysis included paired student's t-test, random effects meta-
analysis to assess the cohort's health status and Bland-Altman analysis.
Results
17 patients (61%) were free from AF at follow-up. Bland-Altman analysis showed good
coefficients of variation. Of all 195 parameters, 27 changed (14%): 9 improved
significantly (5%), 12 worsened significantly (6%), whereas 6 parameters worsened not
significantly (3%). 18 of 120 systolic parameters changed (15%), 14 worsened (12%),
4 improved (3%). In 9 of 75 diastolic parameters, values changed (12%): 5 improved
(7%) and 4 worsened (5%). Meta-analysis revealed that our collective's FT values at
baseline didn't differ significantly from healthy volunteers' values (Q values of 0.01 [p
value 0.921] and 1.499 [p value 0.221]).
Conclusion
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AF patients undergoing ablation appear to have near normal cardiac wall motion,
which does not improve following successful ablation. Feature tracking analysis is a
reliable tool to determine treatment effects but is more likely to show positive findings if
the population is unhealthy.
Response to Reviewers: Reviewer #1: We would like to thank this reviewer for the thoughtful comments and
suggestions. We address these below and have revised our manuscript accordingly.
We feel this process has significantly improved the revised manuscript.
The observer variability of longitudinal strain seems to be very high, which tracking
algorithm software release did you exactly use?
After consulting TomTec Imaging Systems GmbH we could ascertain that tracking
algorithm software 2D CPA-MR Ver. 1.1.2.36 – b. 120712 was used during our
analysis. The intra-observer variability in the 4-chamber view is possibly affected by the
breath-dependent position of the diaphragm [see reference 7 in the manuscript]. Our
variability for most parameters is comparable to previously published data.  However,
we are grateful that this reviewer noted that our longitudinal strain variability was higher
than in two previously reported studies (our data 25.6%, 12.3% for Augustine et al
(JCMR 2013, see reference 7 in the manuscript), 17.3% for Schuster et al (EJR 2013,
see reference 23 in the manuscript). As both other studies do not report the tracking
algorithm version details it is difficult to speculate on the reasons for this difference in
longitudinal strain variability.
How did you calculate mean longitudinal and circumferential strain?
We apologize for the lack of clarity in the manuscript. In order to clarify this detail in our
methods section, we added the following sentence to the revised manuscript:
„Consequently, a curve of mean tracking values over the cardiac cycle was generated.“
Where do you exactly see the clinical field of application of this approach? Please
highlight this in your results and discussion.
We agree that it is important to outline the potential clinical utility of this technology and
have added text to the manuscript as follows:
“The use of semi-automated feature tracking software for detailed analysis of systolic
and diastolic function has now been validated in several studies. This paves the way
for clinical studies examining its utility in a number of potential areas, such as
quantifying mechanical dyssynchrony and patient selection for CRT, assessment of
ischaemia and viability, early detection of cardiomyopathies such as hypertrophic
cardiomyopathy or arrhythmogenic cardiomyopathy and possibly detection of genotype
positive but apparently phenotype negative patients.“
What is the benefit for the patient when using this technique before and after ablation.
Again we agree this should be explained and have added text following on from the
paragraph above as follows.
“The application of this technology to AF is particularly exciting because its aetiology is
likely multifactorial and may well involve abnormalities of cardiac function and
haemodynamics in a proportion of patients which causes atrial remodelling and
thereby promotes AF [24,25]. The onset of AF may also precipitate heart failure in
some patients and increases mortality in those with pre-existing heart failure [26,27]. A
greater understanding of what abnormalities promote AF, how AF adversely affects the
heart, and who will respond best to restoration of sinus rhythm will better equip us to
prevent AF with upstream therapies and help select patients for curative strategies.”
Can you identify responder?
This would be an interesting question to answer and an answer in itself to your
previous question about the potential clinical use of feature tracking in ablation
candidates. However, our data do not allow this prediction of responders, as the
baseline values are too normal. We think, that future studies should try to seek this out
by recruiting a patient group with reduced cardiac function.
Feature tracking provides a lot of parameters. Which are the relevant ones? Please
focus in your paper.
Again, we fully agree that it would be very helpful to decrease the amount of
parameters that have to be observed. We analysed all the parameters to be able to
demonstrate which components would change (e.g. systolic vs diastolic, longitudinal vs
radial etc). As there is no prior data on which strain component may be altered first, we
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could not pre-specify one or two parameters. We are aware of the potential for
multiplicity issues leading to false rejection of null hypotheses tested. This is why we
did not claim clinical significance for single statistically different values.
Reviewer #2: We would like to thank this reviewer for the thoughtful comments and
suggestions. We address these below and have revised our manuscript accordingly.
We feel this process has significantly improved the revised manuscript.
Please re-arrange the descriptive part and probably use abbreviations to make it less
confusing
We thank the reviewer for this comment. We replaced several words by using their
aforementioned abbreviations. As far as the feature tracking terms are concerned, we
followed the often-advised avoidance of abbreviations since the reader is not yet
familiar with these special terms. If the reviewer, editor and publishers feel otherwise,
we would be happy to create abbreviations.
A pre-post table only of the parameters that changed with their individual p values
might be more descriptive than the overall figure 2.
We thank the reviewer for this valuable comment. We have changed this as suggested.
Please see Table 2  in the revised table document.
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 Introduction  
Atrial fibrillation (AF) is the most common heart arrhythmia. It is associated with a reduction 
in quality of life, an increase in disease-related hospitalizations, complications such as stroke 
and heart failure as well as increased mortality [1]. Hence, treatment of AF is important to 
lower the rate of these complications.  
By isolating the initiating foci of AF, catheter ablation has emerged as an effective and 
potentially curative treatment option in patients with paroxysmal and persistent AF. 
Furthermore, reverse atrial remodelling and functional improvement of the left atrium (LA) 
has been reported after successful ablation procedures [2,3]. Similarly, restoration of sinus 
rhythm may result in an improvement of left ventricular (LV) function, especially diastolic 
function [4-6].  
Cardiovascular magnetic resonance (CMR) is considered the gold standard in assessing global 
and regional cardiac function due to its high accuracy and excellent reproducibility [4]. CMR 
feature tracking, which is a novel post-processing technique similar to echocardiographic 
speckle tracking, which tracks regional myocardial features throughout the cardiac cycle. 
With this technique, myocardial strain and velocity measurements can be derived directly 
from cine images [7]. 
Earlier studies have shown that LV ejection fraction (EF) improves in successfully ablated 
patients with systolic heart failure [8-10]. However, ejection fraction is a fairly crude 
parameter of systolic function, and a preserved ejection fraction does not exclude subtle 
abnormalities of both systolic and diastolic function. Morton et al. summarize that impaired 
myocardial strain can occur without any detectable changes in LV volumes or function. They 
furthermore conclude that strain imaging may allow early or subtle detection of abnormalities 
[4]. 
revisedManuscript
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 Consequently this study aimed to analyse existence and reversibility of subclinical cardiac 
dysfunction following atrial fibrillation ablation using CMR feature tracking. 
 
 
Methods 
Study population 
This is a prospective single centre study. Consecutive consenting patients with paroxysmal 
AF refractory to medical management were recruited for catheter ablation. Patients were 
randomly allocated to undergo pulmonary vein isolation by wide are circumferential ablation 
(WACA) using radiofrequency energy or ostial cryo-ablation with the cryo-balloon (Cryo). 
CMR was performed pre-ablation and repeated at 3 months post ablation. 
Patients were excluded from recruitment if they showed persistent atrial fibrillation since 
persistent atrial fibrillation diminishes the quality of MR imaging. 
Informed consent to the CMR examinations was obtained from all study patients. The study 
was approved by a local research ethics committee (UK) and performed in accordance with 
local data protection laws and regulations. 
 
Control subjects 
In order to investigate the health status of our cohort of AF patients with regard to feature 
tracking parameters, a meta-analysis was performed to compare published healthy volunteers’ 
tracking data to our data at baseline. We searched PubMed throughout January 2013 using the 
search term “feature tracking cardiac MRI“. Studies were considered as suitable, if they 
reported strain values in a healthy cohort. In addition, expert opinions (S.E.P., W.H.S.) were 
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 obtained, whether any potentially relevant study was missed. Consequently, the data of these 
manuscripts were analysed in order to get representative comparison data for a healthy 
reference collective. 
 
Catheter ablation procedure 
The catheter ablation procedure was aimed at electrical isolation of all pulmonary veins (PV) 
from the LA and has been described in more detail elsewhere [11]. In brief, pulmonary vein 
isolation (PVI) was achieved by applying either radiofrequency energy (WACA) or freezing 
(Cryo). For WACA a 3.5mm irrigated ablation catheter (Thermo-Cool Celsius
®
 or Navistar
®
, 
Biosense Webster, CA, USA) was used to place contiguous lesions in the left atrium 1-2 cm 
from the pulmonary vein ostia to isolate them as ipsilateral pairs. For Cryo, a cryo-balloon 
(Arctic Front
®
, Medtronic, CA, USA) was inflated in the left atrium and advanced into the 
pulmonary vein ostia to isolate each vein at its ostium. 
PVI was then confirmed by a PV mapping catheter as described previously [12]. 
 
Follow-up 
To determine therapeutic success, patients were asked to undergo a cardiac assessment three 
and six months post ablation procedure. After seven days of ambulatory ECG monitoring at 
these visits, intervention success was defined as absence of AF or any other atrial 
tachyarrhythmia lasting ≥ 30 seconds without taking anti-arrhythmic drugs subsequent to a 
three month blanking period, following current guidelines [13]. 
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 Cardiovascular Magnetic Resonance (CMR) protocol 
MR imaging was performed on a 1.5T MR-scanner (Achieva
®
, Philips Healthcare, 
Eindhoven, The Netherlands) using a 32-channel surface coil (Invivo
®
, Orlando, FL, US).  
Balanced Steady-State Free Precession (SSFP) cine images were acquired in the 2-chamber, 
4-chamber and the short-axis orientations to perform LV function analysis. Typical scan 
parameters were: TR/TE = 3.2/1.6 ms, SENSE parallel imaging acceleration factor = 1.5 to 2, 
slice thickness = 8 mm, slice gap = 2 mm, 1.9×2 mm
2
 acquired spatial resolution and 30 
cardiac phases with 67% phase sharing. In addition, left atrial cines covering all of the atria 
(12 slices) were acquired in the same orientation as the short-axis stack using a 5 mm slice 
thickness and no slice gap. 
Image Analysis 
All images were anonymized and then analyzed by two independent observers (F.C., 4 
months standardised training of CMR image analysis and S.E.P., 14 years of CMR 
experience).  
Volumetry 
All measurements were assessed using certified software (cvi
42©
, Circle Cardiovascular 
Imaging Inc., Calgary, CA). Endocardial and epicardial contours were drawn manually for 
volumetry of the LV at end-systole and end-diastole on all short-axis slices. To define the 
most basal image, both observers took into account a content of circumferential myocardium 
of at least 50% and a visual control of the short-axis slice position on the 4-chamber view as 
described previously [14,15,5]. Papillary muscles and trabeculations were excluded from LV 
mass and included in volume calculations. To measure left atrial volumes, contours were 
drawn with the multiple slice method using the same end-diastolic and end-systolic cardiac 
phases as determined from LV volumes [16]. Pulmonary veins were excluded at their ostia 
and the left atrial appendage was excluded at its base. LA volume was automatically 
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 calculated from all the included slices. Subsequently, LV and LA function was determined by 
calculating the ejection fraction with the following formula: ejection fraction = 100*(EDV–
ESV)/EDV [%], where EDV is the end-diastolic and ESV the end-systolic volume. 
Feature Tracking 
Feature tracking analysis was performed using dedicated software (Image-Arena
©
, Version 
4.6, TomTec Imaging Systems GmbH, Unterschleissheim, GERMANY). Both epi- and 
endocardial LV contours were drawn in order to achieve best tracking results. Furthermore, 
we explored the software’s ability to track endoatrial contours in the LA. All contours were 
tracked semi-automatically in all views. The first slice was used to draw a contour that was 
then automatically propagated by the software to all slices of the cardiac cycle. Manual 
correction was performed where the automated tracking visually seemed to be inaccurate. 
Tracking data were only saved when the contours seemed to be accurate. 
The following parameters were obtained: endocardial velocity (reflecting the speed of the 
endocardium; measured in cm*s
-1
 for radial and longitudinal velocities or deg*s
-1
 for 
circumferential velocities), strain (reflecting thickening/thinning in short-axis plane and 
shortening/lengthening in long-axis plane; indicated in percentage), endocardial strain rate 
(reflecting speed at which deformation occurs; measured in deformation*s
-1
) and torsion 
(reflecting torsion between the base and the apex of the LV; calculated by dividing the 
difference of the absolute values of the circumferential velocities of the basal and the apical 
slice by their distance (4 cm), indicated in deg*s
-1
*cm
-1
). 
The 2- and 4-chamber views were used to determine all longitudinal parameters. Radial 
parameters were derived from both short-axis (LV only) and long-axis views (LV and LA). In 
the short-axis views, three slices were analysed: The nearest slice to the base in which a 
complete circle of myocardium was trackable throughout the cardiac cycle was selected as the 
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 basal slice. The mid-ventricular and apical slice was then chosen with sequential 2 cm gaps 
towards the apex [17]. 
Post-analysis processing included averaging of the values of the software-created 48 tracking 
points for each slice. Consequently, a curve of mean tracking values over the cardiac cycle 
was generated. Based on the corresponding time frame of the smallest ventricular area in the 
mid-ventricular short-axis slice, end-systolic time was determined for all views. To 
distinguish systolic from diastolic left heart function, the following values were calculated for 
velocities and strain rates: peak value during systole, time to systolic peak, time to systolic 
peak-systolic time-ratio, reverse peak value during diastole, diastolic time to reverse peak and 
diastolic time to diastolic peak-diastolic time-ratio. For strain and torsion values (unimodal 
shapes) time to peak was divided by the cardiac cycle length.  
 
Statistics 
All continuous variables were tested for normal distribution using the Kolmogorov-Smirnov 
tests.  Normally distributed variables are presented as mean ± standard deviation (SD). 
Nonparametric data are presented as median plus inter-quartile range, categorical variables 
are presented as frequencies and percentages. 
Feature tracking values of AF patients after ablation were compared to the pretherapeutic 
values using the student’s t-test for dependent samples in order to assess the effect of AF 
ablation on feature tracking parameters. A change in parameter was considered as 
improvement if either the peak value increased, the reverse peak increased in absolute value, 
the time to peak decreased, or the peak occurred earlier in the cardiac cycle. In analogue, a 
change in parameter was considered as worsening if either the peak value decreased, the 
reverse peak decreased in absolute value, the time to peak increased, or the peak occurred 
later in the cardiac cycle. 
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 We performed a random effects meta-analysis to determine the mean and 95% confidence for 
healthy controls from published literature using TomTec’s feature tracking software. We then 
compared baseline strain data derived from our patients at baseline with the effect size for 
healthy controls derived by meta-analysis using tests for heterogeneity and we report the Q 
value and corresponding p value. 
To assess intra-observer variability, F.C. analysed ten randomly selected pairs of datasets 
(each containing a baseline and follow-up CMR) twice with 2 months in between analyses. 
Intra-observer variability data are presented using the Bland and Altman approach 
determining the mean difference (mean bias) and the limits of agreement  (±1.96 SD and the 
coefficient of variability [SD of mean difference divided by sample mean] is reported). 
A p value of less than 0.05 was considered statistically significant. The number and direction 
of statistically significant effects were used to draw conclusions about presence of true 
effects. All statistical analyses were performed using dedicated software (SAS
®
 Version 9.3; 
SAS Institute Inc., Cary, NC, US and Comprehensive Meta Analysis
® 
Version 2.2; Biostat, 
Englewood, NJ, US). 
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 Results 
 
Patient population 
Patients’ were recruited between November 2010 and January 2012.  
28 patients underwent CMR imaging both before (mean: 3±3 days) and three months (3.4 
±1.1 months) after ablation procedure (56 scans in total). 17 patients were treated with 
WACA and 11 with Cryo. Median duration of AF before ablation was 51 months (IQR 24-
84). AF in all patients was refractory to at least one anti-arrhythmic drug (IQR 1-3, previous 
use of amiodarone in 8 patients). 12 Patients had hypertension (40%), 3 had previous stroke 
(10%) and 3 had a history of ischemic heart disease (10%). None of the patients were diabetic 
or had significant valvular disease (defined as ≥ moderate regurgitant or stenotic valvular 
lesion). 17 patients (61%) were free from AF at three months after a single procedure, and this 
was sustained at six months follow-up. 9 successes occurred in the cryoablated group (82%), 
8 in the WACA group (47%). All recurrent arrhythmia was paroxysmal, and hence all patients 
were in sinus rhythm at baseline and three months scans. 
Patient demographics are shown in table 1. 
 
Results from intra-observer variability analysis 
Figure 1 shows Bland-Altman plots for the intra-observer variability analysis. It shows a good 
agreement between the two repeated measurements with coefficients of variation ranging 
from 1.7% (end diastolic volume) to 25.6% (longitudinal strain). 
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 Cardiac volumes and function 
LV EF was within the normal range and remained stable (57±7% at baseline vs 55±7% at 
follow-up; p value 0.645) [18-20]. Mean LA EF was 39±11%. Mean maximum LA volume 
was 116±34 mL. 4 subjects had a reduced LV EF of <50% (14%).  
 
Feature tracking data 
Feature tracking analysis both for LV and LA was feasible in all patients (see figure 2). Mean 
heart rate did not change significantly between baseline and follow-up (63±13 vs. 67±15 bpm; 
p value 0.298).  
Among all 195 velocity, strain, strain rate and torsion parameters assessed by feature tracking, 
27 showed a change (14%). The following 9 improved significantly (5% of parameters 
assessed): time to peak of LA radial velocity, both time to reverse peak and its ratio to 
diastolic length of LV longitudinal velocity, time to peak of LV apical strain rate, the reverse 
peaks of LV and LA longitudinal and radial strain rates and both time to peak and its ratio to 
the cardiac cycle length of left ventricular torsion. The following 12 parameters (6%) 
worsened significantly: peak radial velocities of both all LV short axis slices (see figure 3) 
and LA long axis view, peak strain of LV mid-ventricular and apical circumferential strain, 
time to peak ratio of LV long axis and basal short axis strain, time to peak of left atrial 
longitudinal strain and reverse peaks of all three LV circumferential strain rates.  
Furthermore, 6 parameters worsened, but not significantly (3%).  
With regard to systolic and diastolic parameters, we could observe changes in 18 of 120 
systolic parameters (15%): 14 worsened (12%) and 4 improved (3%). In 9 of 75 diastolic 
parameters, values showed changes (12%): 5 improvements (7%) and 4 worsening (5%). 
Repeat analyses, excluding the 6 patients with impaired LV EF (<50%) or those patients with 
unsuccessful ablation showed no significant differences in our findings.  
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 All changes in feature tracking values are summarized in table 2. 
 
Meta-analysis 
The results from the meta-analysis revealed that mean circumferential and longitudinal strain 
values of our patient collective at baseline didn’t show significant differences to the values 
derived from healthy subjects in previously published studies [21,22,4,23,7,6] (see figure 4). 
This lack of significant difference was reflected in Q values for circumferential strain of 0.01 
(p value 0.921) and for longitudinal strain of 1.499 (p value 0.221). 
 
 
 
Discussion 
The main finding of our study is firstly that in this cohort of patients with AF there were no 
subtle abnormalities of systolic or diastolic function as a plausible underlying aetiology 
compared to normal controls in the literature. Secondly, elimination of paroxysmal AF by 
catheter ablation did not have a clear benefit in terms of LV function, albeit in a cohort with 
mostly normal LV function at baseline. The intra-observer variability suggest that semi-
automated analysis using feature tracking software is feasible and robust and does not explain 
a lack of change due to large variability of outcome measures. In fact, our power calculation 
suggests, this is unlikely to be due to too small a sample size. The use of semi-automated 
feature tracking software for detailed analysis of systolic and diastolic function has now been 
validated in several studies. This paves the way for clinical studies examining its utility in a 
number of potential areas, such as quantifying mechanical dyssynchrony and patient selection 
for cardiac resynchronization therapy, assessment of ischaemia and viability, early detection 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 of cardiomyopathies such as hypertrophic cardiomyopathy or arrhythmogenic 
cardiomyopathy and possibly detection of genotype positive but apparently phenotype 
negative patients.   
The application of this technology to AF is particularly exciting because its aetiology is likely 
multifactorial and may well involve abnormalities of cardiac function and haemodynamics in 
a proportion of patients which causes atrial remodelling and thereby promotes AF [24,25]. 
The onset of AF may also precipitate heart failure in some patients and increases mortality in 
those with pre-existing heart failure [26,27]. A greater understanding of what abnormalities 
promote AF, how AF adversely affects the heart, and who will respond best to restoration of 
sinus rhythm will better equip us to prevent AF with upstream therapies and help select 
patients for curative strategies.  
To our knowledge, this is the first study analysing deformation properties of both chambers of 
the left heart separately for systole and diastole by CMR feature tracking techniques in 
patients with AF. By studying patients pre- and post ablation we were able to study the effect 
of restoring sinus rhythm. 
To assess whether feature tracking software allows a reliable analysis in patients with a 
history of AF, we performed an intra-observer variability analysis. Numerous publications 
focussing on feature tracking observer variability and inter-study reproducibility have shown 
that global circumferential and longitudinal strain parameters tended to be the most 
reproducible. Whilst Augustine et al. indicate coefficients of variation of 2.8% for 
circumferential and 12.3% for longitudinal measurements, Schuster et al. report 13.3% and 
17.3%, respectively [7,23]. Our results are in line with these numbers and support the notion 
that circumferential strain is the most reproducible measure of strain. Longitudinal strain 
showed a relatively high variation in our analysis. An explanation for this is that the 4-
chamber view is possibly affected by the breath-dependent position of the diaphragm as 
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 suggested by Schuster et al. [22]. Future studies should investigate whether these variations in 
variability and reproducibility could possibly be caused by physiological variations in heart 
rate or on differences in imaging resolution. 
Results from our analysis of LV and LA function reveal that only minor changes in velocities, 
strains and strain rates were measurable with the feature tracking technique three months after 
ablation procedures. Since feature tracking is a relatively new tool in image analysis, this 
study is the first to investigate its clinical applicability in a cohort of patients with paroxysmal 
AF. Previous studies investigated cardiac wall motion in AF patients undergoing ablation 
using echocardiography speckle tracking analysis. Although the imaging modalities that 
underlie the two tracking techniques differ, they both aim to measure the same motion 
parameters. Whilst a number of studies could detect changes in both atrial and ventricular 
wall motion after ablation with the use of the speckle tracking technique [28-31], we could 
not observe similar changes of strains or velocities. One possible explanation for this might be 
that follow-up imaging at only three months after ablation procedures was too early to show 
delayed improvements in motion values. Tops et al. found significant changes in atrial strain 
and strain rate at 13±7 months follow-up after radiofrequency ablation [31], whereas Reant et 
al. assessed LV strain more frequently at 1 and at 6 and 12 months [30]. They showed that LV 
function improved progressively during the first year and differed significantly from baseline 
only at the end of follow-up.  
Another possible explanation could be found in the differing imaging modalities that underlie 
the two tracking techniques mentioned: Whilst echocardiography has the advantage of 
superior temporal resolution, CMR is superior in spatial resolution.  In terms of endocardial 
border tracking during the cardiac cycle both excellent temporal and spatial resolution are 
desirable. The attempt to increase temporal resolution with maintained spatial resolution in 
CMR results in prolonged breath-hold time for the patient. However, clinical applicability of 
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 extended scan times remains a limitation. Further development of real-time cardiovascular 
magnetic resonance imaging could provide a solution to the limited frame rate in current 
CMR techniques compared to echocardiography as previously suggested by Nagel et al. [32]. 
In order to explore our patients’ health status with regard to cardiac wall motion, we analyzed 
peak strain values of 266 healthy subjects from six studies. Results from this meta-analysis 
suggest that mean strain values of our patient cohort at baseline are very similar to the non-
AF populations’ values. Consequently, we assume that our AF patients did not have altered 
cardiac deformation before the ablation procedure. This would suggest that a possible post-
ablation improvement in cardiac deformation parameters might therefore not have been 
feasible. Certain characteristics of our cohort may support this assumption: Whilst Reant et al. 
examined patients with an average duration of atrial fibrillation of 9 years, our patients 
underwent ablation procedures significantly earlier [30]. Furthermore, our cohort consisted 
only of patients with paroxysmal AF (self-terminating, usually within 48 hours), whereas 
previous studies included patients with persistent AF (AF episode either lasts longer than 7 
days or requires termination) at considerable rates (24%-33%) [33,28,31]. Schneider et al. 
reported lower strain values in subjects with persistent AF as compared to paroxysmal AF and 
consequently our analysis might be influenced by the exclusion of patients with persistent AF 
[34]. However, we only included patients with paroxysmal AF who were in sinus rhythm at 
the time of imaging in order to get best imaging quality. Finally, mean LA EF in our cohort 
was 39±11% already at baseline, whereas Jahnke et al. found similar values only after 
successful ablation procedure (32±17% at baseline, significant improvement to 41±13% three 
months after ablation) [35]. 
The data of the current study must be interpreted in the context of the study design. First, 
although a power calculation suggests a power of around 90%, our cohort was limited in size 
and detection of changes might still have been missed. However, our study design was based 
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 on previously reported sample size calculations: Morton et al. suggested a sample size of 29 
to detect a change in strain of 5% with 90% power and  error of 0.05 [36]. Secondly, the 
follow-up imaging in our study may have been performed too early to find relevant changes 
in feature tracking parameters. Future studies should investigate the long-term changes in 
cardiac wall motion with the help of feature tracking analysis. Finally, our study design did 
not include a healthy control group. We tried to overcome this by performing a meta-analysis 
of 266 healthy subjects from 6 published studies. Well-matched control groups are needed in 
future studies to better understand possible differences in feature tracking values of AF 
patients and healthy subjects. 
In conclusion, feature tracking analysis appears to be a useful and reliable tool to determine 
treatment effects. Paroxysmal AF patients with grossly preserved LV ejection fraction do not 
appear to have subtle abnormalities of cardiac wall motion as an underlying aetiology. In this 
population with normal cardiac function at baseline, there were no subtle improvements in  
cardiac systolic or diastolic function detected following successful ablation.  
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 Figure legends 
 
Figure 1: Intra-observer variability for the assessment of left ventricular 
circumferential and longitudinal strain and volumes. 
EDV=end-diastolic volume; ESV=end-systolic volume; COV=coefficient of variation 
 
Figure 2: Feasibility of feature tracking velocity analysis in left ventricle and 
atrium 
Feature tracking analysis shown for radial and longitudinal velocities of the left ventricle (above) and the 
left atrium (below). The 48 blue lines reflect tracking of the endocardial borders. The length of the green 
vectors (middle) reflects absolute values of velocities.  
Figure 3: Radial velocity curve of endocardium (short axis mid-ventricular view). 
Figure showing baseline (red) and three-month follow-up (red) curve of radial velocity [cm*s-1] in mid-
ventricular short axis view. Vertical arrows indicate peak velocities. 
Figure 4: Comparison of baseline strain values with previously published strain 
values derived from feature tracking analysis. 
AF= atrial fibrillation; CI=confidence interval 
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Tables 
 
Table 1: Patients’ baseline characteristics 
  
Patients 
n=28 
Age yrs 61 (51-69) 
Male gender n 20 (71) 
    
Duration of AF mo 51 (24-84) 
Anti-Arrhythmic drugs failed n 2 (1-3) 
Hypertension n 12 (40) 
Previous stroke n 3 (10) 
Ischaemic heart disease n 3 (10) 
Diabetes n 0 (0) 
    
Time between baseline CMR and ablation d 3 (3) 
Time between ablation and follow-up CMR mo 3.4 (1.1) 
    
Left ventricular EF % 57 (7) 
Left atrial EF % 39 (11) 
Maximum left atrial volume mL 116 (34) 
      
Wide area circumferential radiofrequency ablation n 17 (61) 
Ablation success at 3 and 6 months follow-up n 17 (61) 
  Wide area circumferential ablation n 8 (47) 
  Cryoablation n 9 (82) 
 
yrs=years; mo=months; d=days; EF=ejection fraction; CMR= cardiovascular magnetic resonance;  
Nonparametric data are presented as median plus inter-quartile range, categorical variables are presented as frequencies and 
percentages. 
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Table 2: Summary of changes of all feature tracking parameters 
  
Radial Circumferential Longitudinal 
LV short axis LV long axis LA long axis LV short axis LV long axis LA long axis 
b m a 2ch 4ch 2ch 4ch b m a 2ch 4ch 2ch 4ch 
Velocity 
S
Y
S
 
Peak 
↓ ↓ ↓   ↘ ↓ 
  
  
  
  
 
    
0,014 0,025 0,028   0,057 0,006     
T2p 
   ↗   ↓     
   0,072   0,004     
T2p/SYS 
   ↗        
   0,059        
D
IA
 
Reverse Peak 
      ↘     
      0,054     
T2rp 
       ↓    
       0,025    
T2rp/DIA 
       ↓    
       0,047    
Strain 
R
-R
 
Peak 
        ↓ ↓     
        0,003 0,008     
T2p 
       ↗       
       0,056       
T2p/RR 
    ↑   ↑ ↗      
    0,022   0,005 0,094      
Strain 
Rate 
S
Y
S
 
Peak 
              
              
T2p 
  ↓           ↑ 
  0,034           0,045 
T2p/SYS 
              
              
D
IA
 
Reverse Peak 
   ↓    ↑ ↑ ↑ ↓   ↓ 
   0,049    0,015 0,014 0,006 0,032   0,044 
T2rp 
              
              
T2rp/DIA 
              
              
Torsion 
R
-R
 
Peak 
  
 
  
 
T2p 
↓ 
0,028 
T2p/RR 
↓ 
0,087 
 
R-R=cardiac cycle; b=basal; a=apical; m=midventricular; LV=left ventricle; LA=left atrium; 2ch=2-chamber view; 4ch=4-
chamber view; T2p = time to peak; T2rp = time to reverse peak 
Red arrows indicate significant worsening of values and the direction (decreased or increased absolute values), green arrows 
indicate significant improvement of values and direction (increased or decreased absolute values) (p value < 0.05). Values that 
nearly reached significance (p value >0.05 but < 0.10) are indicated as orange arrows and reflect worsening. P Values are 
indicated below the arrows. 
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Thank you very much for your email regarding our submission ID CAIM-D-13-00266 entitled "Effect 
of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature 
tracking analysis". We are very pleased that the reviewers have recommended publication.  
We appreciate a lot the comments regarding the manuscript, which we have addressed in a separate 
rebuttal section below. We valued the reviewers’ comments and suggestions and hope that this revised 
and improved manuscript is acceptable for publication in The International Journal of Cardiovascular 
Imaging. 
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